MX2018006329A - Agente terapeutico para cancer de mama. - Google Patents

Agente terapeutico para cancer de mama.

Info

Publication number
MX2018006329A
MX2018006329A MX2018006329A MX2018006329A MX2018006329A MX 2018006329 A MX2018006329 A MX 2018006329A MX 2018006329 A MX2018006329 A MX 2018006329A MX 2018006329 A MX2018006329 A MX 2018006329A MX 2018006329 A MX2018006329 A MX 2018006329A
Authority
MX
Mexico
Prior art keywords
therapeutic agent
breast cancer
methoxyethoxy
benzamide
piperidin
Prior art date
Application number
MX2018006329A
Other languages
English (en)
Inventor
Yamamoto Yuji
Miyano Saori
Nakagawa Takayuki
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2018006329A publication Critical patent/MX2018006329A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente solicitud describe un agente terapéutico para el cáncer de mama que comprende 5-((2-(4-(1-(2-hidroxietil)piperidin- 4-il)benzamido)piridin-4-il)oxi)-6-(2-metoxietoxi)-N-metil-1H-ind ol-1-carboxamida o una sal farmacológicamente aceptable de esta.
MX2018006329A 2015-12-17 2016-12-15 Agente terapeutico para cancer de mama. MX2018006329A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015246308 2015-12-17
PCT/JP2016/087349 WO2017104739A1 (ja) 2015-12-17 2016-12-15 乳がん治療剤

Publications (1)

Publication Number Publication Date
MX2018006329A true MX2018006329A (es) 2018-08-29

Family

ID=59056770

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006329A MX2018006329A (es) 2015-12-17 2016-12-15 Agente terapeutico para cancer de mama.

Country Status (13)

Country Link
US (1) US20180303817A1 (es)
EP (1) EP3391885B1 (es)
JP (1) JP6858132B2 (es)
KR (1) KR102486722B1 (es)
CN (2) CN108367000A (es)
AU (1) AU2016374441B2 (es)
CA (1) CA3001969C (es)
ES (1) ES2867804T3 (es)
IL (1) IL258671A (es)
MX (1) MX2018006329A (es)
RU (1) RU2730503C2 (es)
SG (2) SG10201913213WA (es)
WO (1) WO2017104739A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202001481PA (en) * 2017-10-12 2020-03-30 Eisai R&D Man Co Ltd Pharmaceutical composition comprising fgfr selective tyrosine kinase inhibitor
JPWO2019189241A1 (ja) 2018-03-28 2021-03-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 肝細胞癌治療剤
EP4122465A4 (en) 2020-04-17 2024-03-20 Eisai R&D Man Co Ltd THERAPEUTIC AGENT AGAINST BREAST CANCER
AU2021315234A1 (en) * 2020-07-31 2023-01-19 Eisai R&D Management Co., Ltd. Therapeutic agent for breast cancer
JPWO2022092085A1 (es) 2020-10-28 2022-05-05

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7098332B2 (en) * 2002-12-20 2006-08-29 Hoffmann-La Roche Inc. 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
AR094812A1 (es) * 2013-02-20 2015-08-26 Eisai R&D Man Co Ltd Derivado de piridina monocíclico como inhibidor del fgfr
CA2956270C (en) * 2014-08-18 2022-08-09 Eisai R&D Management Co., Ltd. Salt of monocyclic pyridine derivative and crystal thereof

Also Published As

Publication number Publication date
RU2018119102A (ru) 2020-01-17
CN108367000A (zh) 2018-08-03
EP3391885B1 (en) 2021-03-17
CA3001969A1 (en) 2017-06-22
KR20180094862A (ko) 2018-08-24
CN115177619A (zh) 2022-10-14
AU2016374441B2 (en) 2021-10-21
SG11201803118WA (en) 2018-05-30
RU2018119102A3 (es) 2020-02-04
US20180303817A1 (en) 2018-10-25
EP3391885A4 (en) 2019-08-28
JPWO2017104739A1 (ja) 2018-10-04
EP3391885A1 (en) 2018-10-24
SG10201913213WA (en) 2020-03-30
ES2867804T3 (es) 2021-10-20
IL258671A (en) 2018-06-28
BR112018010103A2 (pt) 2018-11-21
CA3001969C (en) 2023-10-03
AU2016374441A1 (en) 2018-05-10
JP6858132B2 (ja) 2021-04-14
KR102486722B1 (ko) 2023-01-11
WO2017104739A1 (ja) 2017-06-22
RU2730503C2 (ru) 2020-08-24

Similar Documents

Publication Publication Date Title
MX2017009892A (es) Agente terapeutico contra el colangiocarcinoma.
MX2018006329A (es) Agente terapeutico para cancer de mama.
NZ739893A (en) Fused pyrimidine compound or salt thereof
PH12015500275A1 (en) Salts and solid forms of (s)-3-(4-((4-morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
MY185516A (en) Compositions and methods for treating schizophrenia
SG11201600996UA (en) Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
ZA201701132B (en) Novel 2,5-substituted pyrimidines as pde inhibitors
MX366837B (es) Quinolinas carboxamidas para usarse en el tratamiento de mielomas multiples.
MX2015014958A (es) Nuevos derivados de triazolona o sales de la misma y composicion farmaceutica que comprende a la misma.
MX2020008610A (es) Agente terapeutico para carcinoma hepatocelular.
BR112015021324A2 (pt) derivados de 6-[4-(1h-imidazol-2-il)piperidin-1-il]pirimidin-4-amina como moduladores de atividade de quinase
NZ707946A (en) Hydantoin derivative
EP3541801A4 (en) 4- (6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
EP3233824A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
EP3541797A4 (en) 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
HK1217918A1 (zh) 用於治療何杰金氏淋巴瘤的 -氰基- -二甲基環己- -烯- -基 -四甲基四氫- -吡喃- -基 吡啶- -基 -咪唑- -酰胺
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
ZA201801544B (en) 1-(4-(2-((1-(3,4-difluorophenyl)-1h-pyrazol-3-yl)methoxy)ethyl) piperazin-1-yl)ethanone salts
MX2020002083A (es) Composicion farmaceutica que comprende un inhibidor tirosina cinasa selectivo para receptores del factor de crecimiento de fibroblastos (fgfr).
IL244933A0 (en) Pharmaceutical dosage forms containing sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(3,2,1-1h-triazol-1-yl)-1h-pyrazol-5-olate
IL282905A (en) Cycloalkane-1, 3-diamine derivative
TH1601002081A (th) รูปแบบเภสัชภัณฑ์ซึ่งประกอบรวมด้วยโซเดียม 1-[6-(มอร์โฟลิน-4-อิล)ไพริมิดิน-4- อิล]-4-(1h-1,2,3-ไตรอะโซล-1-อิล)-1h-ไพราโซล-5-โอเลต
AU2017904453A0 (en) Process for preparing 2-substituted 3',4'-polyhydroxystilbene compounds
UA88008U (en) 3-(phenoxymethyl)-5-(propylthio)-1h-1,2,4-triazole exhibiting actoprotector activity
IT201700024657A1 (it) Materassino per operazioni chirurgiche.